文献速递慢性静脉疾病

外显子测序揭示PIEZO1罕见蛋白截短变异与静脉曲张相关

Association of varicose veins with rare protein-truncating variants in PIEZO1 identified by exome sequencing of a large clinical population.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2021-08-03

基于Geisinger MyCode社区健康 initiative 131,918名参与者的外显子序列数据库,识别PIEZO1或CASZ1基因变异者,并通过电子健康记录确定静脉曲张诊断。共12,531人(9.5%)诊断为静脉曲张,PIEZO1蛋白截短变异(PTV)在病例中显著富集(0.37% vs 0.22%;OR 1.7;CASZ1的PTV极罕见,静脉曲张者中未发现。

要点

  • PIEZO1罕见PTV与静脉曲张风险升高相关(OR 1.7),尤其是移码或stop-gain变异。
  • PIEZO1 PTV携带者接受静脉消融治疗的风险显著增高(OR 6.9)。
  • CASZ1 PTV极罕见,未在静脉曲张患者中发现,PIEZO1错义变异与静脉曲张无关。

核心结论

  • PIEZO1罕见蛋白截短变异与静脉曲张及需要静脉消融治疗相关,而CASZ1未见关联。

研究设计与样本

  • 基于Geisinger MyCode社区健康倡议的131,918名参与者外显子序列数据库,结合电子健康记录进行病例对照分析。

主要发现

  • 12,531人(9.5%)诊断为静脉曲张,发现305名 heterozygous 携带者中92个PIEZO1 PTV。
  • PIEZO1 PTV与淋巴水肿无关,PIEZO1罕见错义变异与静脉曲张无关;CASZ1 PTV仅16例携带者,静脉曲张者中无。

临床怎么用

  • PIEZO1 PTV可作为静脉曲张遗传风险评估的潜在标志,提示携带者可能更需要血管外科干预和消融治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The present study sought to determine whether protein-truncating variants (PTVs) in PIEZO1 and CASZ1 genes, previously shown to be associated with varicose veins, were associated with an altered risk of varicose veins. METHODS: An exome sequence database of 131,918 participants from the Geisinger MyCode Community Health Initiative was used to identify individuals with genetic variants in the PIEZO1 or CASZ1 gene. Clinical phenotypes, including varicose vein diagnoses, were determined by analysis of the electronic health record data. RESULTS: We identified 12,531 individuals (9.5%) with a diagnosis of varicose veins. Exome sequence data identified 92 PIEZO1 PTVs in 305 heterozygous carriers. PIEZO1 PTVs were significantly enriched in those with varicose vein (0.37% of cases vs 0.22% of controls; odds ratio [OR], 1.7; P = .0010). Nearly all varicose vein cases were associated with frameshift or stop-gain PTVs (OR, 3.0 for stop-gain [P = .0001]; OR, 2.9 for frameshift variants [P < .0001]). In the varicose vein cases, the PTV carriers were more likely to have an encounter with a vascular surgeon (62.5% for PTV carriers; 36.9% for noncarriers; P = .0003) and more likely to have received vein ablation therapy (OR, 6.9; P < .0001). No association was found between PIEZO1 PTVs and lymphedema, and no association was found for rare missense variants in PIEZO1 with varicose veins. PTVs in CASZ1 were extremely rare (16 total carriers), with none identified in those with varicose vein. CONCLUSIONS: Rare PTVs in PIEZO1 but not CASZ1 were associated with varicose veins and the need for vein ablation therapy. These results have demonstrated that PTVs in the PIEZO1 gene are rare but represent strong genetic risk factors for varicose veins and the need for vein ablation therapy. These results have also identified a potential biologic mechanism and target for the development of novel therapies.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Smelser DT, Haley JS, Ryer EJ, et al. Association of varicose veins with rare protein-truncating variants in PIEZO1 identified by exome sequencing of a large clinical population. J Vasc Surg Venous Lymphat Disord. 2021. PMID: 34358671. doi:10.1016/j.jvsv.2021.07.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。